Bombay HC upholds IPAB order on Nexavar’s generic copy3 min read . Updated: 16 Jul 2014, 12:06 AM IST
Bayer, which makes Nexavar, says it is disappointed with the ruling and will appeal against the decision
Mumbai: The Bombay high court on Tuesday dismissed a challenge by Bayer AG against a decision to allow drug maker Natco Pharma Ltd to manufacture and sell a generic copy of a patent-protected cancer drug made by the German company.
Select your Category